Evan Seigerman
Stock Analyst at BMO Capital
(1)
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
VRTX Vertex Pharmaceutica... | Maintains: Outperform | 557 530 | 374.47 | 41.53% | 16 | Aug 5, 2025 | |
INCY Incyte | Maintains: Underperform | 52 60 | 79.21 | -24.25% | 13 | Jul 30, 2025 | |
IRON Disc Medicine | Maintains: Outperform | 112 120 | 58.61 | 104.74% | 6 | May 12, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Market Perform | 96 115 | 123.99 | -7.25% | 15 | May 6, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 115 120 | 120.57 | -0.47% | 17 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 156 139 | 128.03 | 8.57% | 19 | Feb 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 57 61 | 45.94 | 32.78% | 11 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1001 1101 | 635.48 | 73.25% | 8 | Aug 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 17.5 | 128.57% | 1 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 110 59 | 58.7 | 0.51% | 8 | Dec 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 40 | 4.98 | 703.21% | 1 | Oct 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 757 788 | 546.18 | 44.27% | 15 | Aug 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 8 3 | 2.23 | 12.11% | 2 | Aug 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 263 243 | 285.1 | -14.77% | 6 | Apr 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 12 | 6.21 | 93.24% | 2 | Mar 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 60 | 24.61 | 143.8% | 1 | Nov 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 360 324 | 17.16 | 1788.11% | 2 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 | 1.1 | 490.91% | 4 | Mar 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 9 15 | n/a | n/a | 4 | Dec 16, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 35 | n/a | n/a | 4 | Sep 1, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 14 17 | 0.86 | 1853.49% | 6 | Aug 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 30 | 1.47 | 1940.82% | 3 | May 12, 2020 |